Stay updated on Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedTwo new trial sites were added (Thessaloniki, Greece and Bucheon-si, South Korea) and two existing sites were removed, updating the list of study locations. The study plan section was updated to include the double-blind dosing with Week 16 re-randomization and AbbVie’s data-sharing commitments with related links.SummaryDifference0.5%

- Check10 days agoChange DetectedA new publication entry has been added to the Publications section of the study record. It cites Eyerich et al.'s work on Upadacitinib efficacy in atopic dermatitis of the head and neck region (Dermatol Ther Heidelb, 2026; online ahead of print).SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the prior Revision: v3.5.3. This appears to be a maintenance/versioning update to the page's metadata rather than a substantive change to study information.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded the location Taoyuan City, Taiwan, 333 and removed Taoyuan, Taiwan, 333, updating the study's sites list to reflect a more precise city designation.SummaryDifference0.0%

- Check46 days agoChange DetectedThis update refines the administrative naming of a specific Austria location from “Vienna” to “State of Vienna” and updates the page revision label in the footer.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision history updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page.